Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1149120180150020035
Journal of the Korean Society for Psoriasis
2018 Volume.15 No. 2 p.35 ~ p.41
The Screening Tests for biologics use in psoriasis and psoriatic arthritis patients
Choi Hoon

Bae In-Ho
Shin Bong-Seok
Abstract
Psoriasis and psoriasis arthritis are chronic progressive inflammatory diseases with significant comorbidities including autoimmune conditions, cardiovascular diseases, depressive disorder as well as life quality impairment. The purpose of treatment for psoriasis is to improve psoriatic lesions without severe adverse events and prevent long-term recurrence. Since 2002, biologic agent has been introduced as a treatment method for psoriasis and there have been a lot of studies on the safety and efficacy of the biologic agents. In particular, the biologic agents for moderate to severe psoriasis have been widely used. This article is intended to provide a review of the literatures on screening tests for biologic agents in patients with psoriasis and psoriatic arthritis
KEYWORD
Biologics, Psoriasis, Psoriatic arthritis, Screening test
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)